European Parliament

The European Commission should shift funding towards smaller enterprises that cannot participate in Horizon 2020, says the European Parliament’s rapporteur on a new SME initiative

The European Medicines Agency’s thumbs-down for rare disease treatment Glybera flies in the face of Commission policy. It’s also against the wishes of the European Parliament, and the impetus DG Sanco is putting into Orphan Drugs. Worse still, it’s bad for patients and kills innovation. By Nuala Moran.

Cloud computing has become a standard way of working online – and a Science|Business seminar in the European Parliament looked at the impact on small companies

The European Commission has released its official proposal for Horizon 2020, the EU’s new research funding scheme. Science|Business presents a roundup of first reactions from the European capital.

The European Commission’s DG Research director-general Robert-Jan Smits is calling on the European Parliament to help simplify regulations and make the system for public private partnerships more user-friendly

Sixteen of Europe’s top medical research bodies state their case for urgent reform of clinical trials regulations as they begin to prepare the ground for the parliamentary debate on rule changes, expected next year

Biofuels are an important element the EU’s future energy mix, but more research is needed to develop fuels that don’t compete with food, says Csaba Tabajdi MEP

MEPs want to establish conditions where anyone can innovate. But evidence suggests such a protected environment won’t promote entrepreneurialism

A group of MEPs working on plans for the EU’s overall budget from 2014 are pushing for a big boost – to as much as €100 billion - for the next EU research programme, as Maria Da Graça Carvalho, Member of the European Parliament tells Science|Business

The European Parliament gave its approval for a common European patent, allowing the system to move ahead despite objections from Italy and Spain